Krishnamohan Neha, a director at Arcutis Biotherapeutics ($ARQT), made two open market sales of company shares over the past year, totaling nearly $940,000. Her most recent sale occurred on November 13, 2025. These transactions rank her 5,078th among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Neha recorded no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | M | Common Stock | 27052 | $8.63 | 50,407.0000 | 132,885,000 | 115.83% | 0.02% |
| Nov. 13, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | M | Common Stock | 12220 | $7.51 | 62,627.0000 | 132,885,000 | 24.24% | 0.01% |
| Nov. 13, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | M | Stock Option (right to buy) | 12220 | $0.00 | 0.0000 | 132,885,000 | 100.00% | 0.01% |
| Nov. 13, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | M | Stock Option (right to buy) | 27052 | $0.00 | 0.0000 | 132,885,000 | 100.00% | 0.02% |
| Nov. 13, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | S | Common Stock | 39272 | $23.19 | 23,355.0000 | 132,885,000 | 62.71% | 0.03% |
| Nov. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Krishnamohan Neha | Chief Financial Officer | F | Common Stock | 3490 | $3.25 | 99,356.0000 | 24,544,904 | 3.39% | 0.01% |
| Nov. 13, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | S | Common Stock | 1232 | $23.37 | 22,123.0000 | 132,885,000 | 5.28% | 0.00% |
| May 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Krishnamohan Neha | Chief Financial Officer | F | Common Stock | 1341 | $2.13 | 108,659.0000 | 24,363,119 | 1.22% | 0.01% |
| Aug. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Krishnamohan Neha | Chief Financial Officer | F | Common Stock | 5813 | $2.75 | 102,846.0000 | 24,363,119 | 5.35% | 0.02% |
| June 12, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | A | Common Stock | 7609 | $0.00 | 23,355.0000 | 120,957,633 | 48.32% | 0.01% |
| June 12, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | A | Stock Option (right to buy) | 20568 | $0.00 | 20,568.0000 | 120,957,633 | 9999.99% | 0.02% |
| Feb. 26, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Krishnamohan Neha | Chief Financial Officer | A | Common Stock | 60000 | $0.00 | 110,000.0000 | 0 | 120.00% | 0.00% |
| Sept. 12, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | Krishnamohan Neha | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | A | Stock Option (right to buy) | 27052 | $0.00 | 27,052.0000 | 69,305,487 | 9999.99% | 0.04% |
| June 14, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Krishnamohan Neha | Director | A | Common Stock | 10139 | $0.00 | 15,746.0000 | 69,305,487 | 180.83% | 0.01% |